US Broker Ratings

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Potential 152% Upside Captivates Investors

Investors eyeing the biotech sector might want to take a closer look at ARS Pharmaceuticals, Inc. (NASDAQ: SPRY). The company, known for its innovative approach in addressing severe allergic reactions,..

Kestra Medical Technologies (KMTS) Stock Analysis: Strong Revenue Growth Amidst Negative Earnings

Kestra Medical Technologies, Ltd. (KMTS), a burgeoning player in the healthcare sector, has carved out a niche in the medical instruments and supplies industry with its innovative approach to cardiovascular..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Unlocking a 27% Potential Upside in Biotech

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is creating ripples across the biotechnology sector, an industry known for its groundbreaking innovations and volatile market dynamics. With a market cap of $3.1 billion,..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook with a Promising 19.26% Potential Upside

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.87 billion, Aveanna..

10x Genomics, Inc. (TXG) Investor Outlook: Navigating Growth and Challenges in Health Information Services

10x Genomics, Inc. (NASDAQ: TXG) stands as a distinctive player in the healthcare sector, specifically within the health information services industry. With its innovative technology platforms, 10x Genomics has carved..

Pulse Biosciences, Inc (PLSE) Investor Outlook: Exploring a 44.74% Potential Upside

As the healthcare sector continuously evolves with technological advancements, Pulse Biosciences, Inc (NASDAQ: PLSE) stands at the forefront of innovation with its cutting-edge bioelectric medicine solutions. Headquartered in Miami, Florida,..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 14% Potential Upside in the Biotech Arena

Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company headquartered in San Diego, California, is making waves in the biotechnology sector. With a current market cap of $3.27 billion, the company..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A 26% Upside Potential in the Healthcare Sector

For investors with a keen eye on the healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) presents an intriguing opportunity. This Bothell, Washington-based company, specializing in bioproduction products for the cell..

Mineralys Therapeutics, Inc. (MLYS): Exploring a 35% Upside Potential in the Biotech Sector

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a nascent yet promising player in the biotechnology industry, has been capturing the attention of investors with its targeted approach to tackling cardiorenal diseases. With..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a Potential 16.08% Upside for Investors

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector specializing in the development and manufacturing of generic and proprietary pharmaceuticals, is drawing attention from investors with a..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 59% Upside Potential in Biotechnology

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) presents a compelling opportunity for investors intrigued by the intersection of biotechnology and technological innovation. The company, headquartered in Salt Lake City, Utah, is at..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A Biotech Innovator with 64.5% Upside Potential

Beam Therapeutics Inc. (NASDAQ: BEAM) stands out in the biotechnology sector, offering a compelling investment case characterized by its innovative approach to precision genetic medicines and a significant potential upside..

GRAIL, Inc. (GRAL) Stock Analysis: Exploring a 11.29% Upside in the Healthcare Diagnostics Sector

GRAIL, Inc. (NASDAQ: GRAL) is a rising star in the healthcare diagnostics sector, captivating investor attention with its cutting-edge cancer detection technologies and promising growth potential. As a commercial-stage healthcare..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring an 82% Upside Potential in Biotechnology

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a promising player in the biotechnology sector, is making waves with its innovative approach to treating muscle disorders. As a biopharmaceutical company focused on discovering,..

Integra LifeSciences Holdings C (IART) Stock Analysis: Potential 23% Upside Amidst Challenging Metrics

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the healthcare sector specializing in medical devices, presents a complex picture for investors. With a market cap of $979.34 million,..

NeoGenomics, Inc. (NEO) Stock Analysis: Navigating the Diagnostics Frontier with a 12.22% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, continues to attract investor interest with its compelling role in the diagnostics and research industry. With a market capitalization..

Enovis Corporation (ENOV) Stock Analysis: A Compelling 72.79% Upside in the Medical Devices Sector

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, is making waves in the medical devices industry with its innovative approach to clinical solutions. Headquartered in Wilmington, Delaware,..

89bio, Inc. (ETNB) Investor Outlook: Unpacking the 104.68% Potential Upside

89bio, Inc. (NASDAQ: ETNB), a burgeoning player in the biotechnology sector, has emerged as a beacon of potential for investors seeking significant growth opportunities. With a current market capitalization of..

Aurinia Pharmaceuticals Inc (AUPH): Navigating Biotech with a Strong 20.65% ROE and Promising Analyst Ratings

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a key player in the biotech sector, is capturing significant attention with its innovative approach to treating autoimmune diseases, particularly lupus nephritis. Headquartered in Edmonton,..

Indivior PLC (INDV) Stock Analysis: Robust Buy Ratings Signal Growth Potential in Specialty Pharma

Indivior PLC (NASDAQ: INDV), a key player in the healthcare sector, operates within the specialized niche of drug manufacturing, focusing particularly on treatments for opioid use disorder (OUD). With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds